טוען...
Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide. Although a number of promising potential vaccines and therapeutic agents for SARS-CoV have been described, no effective antiviral...
שמור ב:
| Main Authors: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier B.V.
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3205982/ https://ncbi.nlm.nih.gov/pubmed/21820471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2011.07.016 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|